PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

Abstract Margaret McNairy and colleagues highlight the need for clinical decision tools to help identify HIV patients who would benefit from tailored services to avoid poor outcomes such as death and loss to follow-up.
PMID
Related Publications

Antiretroviral therapy in children--increased benefit from increased complexity.

Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort.

Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.

Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.

Authors

Mayor MeshTerms

Antiretroviral Therapy, Highly Active

Decision Support Techniques

Keywords
Journal Title plos medicine
Publication Year Start




PMID- 28419097
OWN - NLM
STAT- MEDLINE
DA  - 20170418
DCOM- 20170501
LR  - 20170501
IS  - 1549-1676 (Electronic)
IS  - 1549-1277 (Linking)
VI  - 14
IP  - 4
DP  - 2017 Apr
TI  - Clinical decision tools are needed to identify HIV-positive patients at high risk
      for poor outcomes after initiation of antiretroviral therapy.
PG  - e1002278
LID - 10.1371/journal.pmed.1002278 [doi]
AB  - Margaret McNairy and colleagues highlight the need for clinical decision tools to
      help identify HIV patients who would benefit from tailored services to avoid poor
      outcomes such as death and loss to follow-up.
FAU - McNairy, Margaret L
AU  - McNairy ML
AD  - ICAP, Columbia University, New York, New York, United States of America.
AD  - Department of Medicine, Cornell Medical College, New York, New York, United
      States of America.
FAU - Abrams, Elaine J
AU  - Abrams EJ
AD  - ICAP, Columbia University, New York, New York, United States of America.
AD  - Department of Epidemiology, Mailman School of Public Health, Columbia University,
      New York, New York, United States of America.
FAU - Rabkin, Miriam
AU  - Rabkin M
AD  - ICAP, Columbia University, New York, New York, United States of America.
AD  - Department of Epidemiology, Mailman School of Public Health, Columbia University,
      New York, New York, United States of America.
FAU - El-Sadr, Wafaa M
AU  - El-Sadr WM
AD  - ICAP, Columbia University, New York, New York, United States of America.
AD  - Department of Epidemiology, Mailman School of Public Health, Columbia University,
      New York, New York, United States of America.
LA  - eng
PT  - Journal Article
DEP - 20170418
PL  - United States
TA  - PLoS Med
JT  - PLoS medicine
JID - 101231360
RN  - 0 (Anti-HIV Agents)
SB  - IM
MH  - Adult
MH  - Anti-HIV Agents/*therapeutic use
MH  - *Antiretroviral Therapy, Highly Active
MH  - Child
MH  - *Decision Support Techniques
MH  - Female
MH  - HIV Infections/diagnosis/*drug therapy/*mortality
MH  - HIV-1
MH  - Humans
MH  - Male
MH  - Prognosis
MH  - Research Design
MH  - Risk Factors
MH  - Treatment Outcome
EDAT- 2017/04/19 06:00
MHDA- 2017/05/02 06:00
CRDT- 2017/04/19 06:00
AID - 10.1371/journal.pmed.1002278 [doi]
AID - PMEDICINE-D-16-03354 [pii]
PST - epublish
SO  - PLoS Med. 2017 Apr 18;14(4):e1002278. doi: 10.1371/journal.pmed.1002278.
      eCollection 2017 Apr.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>